Search results for Avelumab ELISA Kit
Avelumab ELISA Kit, ProteoGenix, KPTX280
Description of Avelumab ELISA Kit The Structure and Activity of Avelumab ELISA Kit A Revolutionary Tool for Antibody Research Introduction Avelumab ELISA Kit is a cutting-edge tool used for the detection and quantification of Avelumab, a monoclonal antibody targeting the programmed death-ligand 1 (PD-L1). This kit is designed for use in scientific research, specifically in the field of immunology and oncology. In this article, we will delve into the structure, activity, and applications of Avelumab ELISA Kit, highlighting its importance as a therapeutic target in cancer treatment. Structure of Avelumab ELISA Kit Avelumab ELISA Kit is composed of several components, including a microplate coated with a specific antibody against Avelumab, a standard solution of known Avelumab concentration, and a detection antibody labeled with an enzyme. The microplate is divided into wells, each of which can hold a specific volume of sample or standard solution. The standard solution serves as a reference for the quantification of Avelumab in the sample. The detection antibody, labeled with an enzyme, binds to the Avelumab present in the sample or standard solution, forming an antigen-antibody complex. This complex can then be quantified using a colorimetric or fluorescent assay, providing a measure of the Avelumab concentration in the sample. Activity of Avelumab ELISA Kit Avelumab ELISA Kit is a highly sensitive and specific tool for the detection and quantification of Avelumab. The kit utilizes the principles of enzyme-linked immunosorbent assay (ELISA) to accurately measure the concentration of Avelumab in a sample. The detection antibody used in the kit is specific for Avelumab, ensuring that only the target antibody is detected. The enzyme attached to the detection antibody catalyzes a colorimetric or fluorescent reaction, providing a signal that is directly proportional to the amount of Avelumab present in the sample. This signal can be measured using a microplate reader, providing a precise and quantitative measure of Avelumab concentration. Applications of Avelumab ELISA Kit Avelumab ELISA Kit has a wide range of applications in scientific research, particularly in the fields of immunology and oncology. One of the key applications of this kit is in the study of PD-L1 expression in cancer cells. PD-L1 is a protein expressed on the surface of cancer cells, which helps them evade the immune system. Avelumab, being a PD-L1 inhibitor, can block this interaction and enhance the immune response against cancer cells. Avelumab ELISA Kit can be used to measure the expression of PD-L1 in cancer cells and evaluate the efficacy of Avelumab as a therapeutic agent. In addition, Avelumab ELISA Kit can also be used to monitor the pharmacokinetics of Avelumab in patients undergoing treatment. By measuring the concentration of Avelumab in the blood, researchers can determine the optimal dosage and frequency of administration for maximum therapeutic effect. Furthermore, Avelumab ELISA Kit can also be used to screen for potential adverse effects of Avelumab treatment. By monitoring the concentration of Avelumab in the blood, researchers can identify any potential toxicity or unwanted immune reactions in patients. Conclusion Avelumab ELISA Kit is a powerful tool for the detection and quantification of Avelumab, a monoclonal antibody targeting PD-L1. Its highly sensitive and specific nature makes it an essential tool for research in the fields of immunology and oncology. With its wide range of applications, Avelumab ELISA Kit is revolutionizing the study of Avelumab and its role as a therapeutic target in cancer treatment.
Host
Reactivity
Applications
Conjugation
Avelumab ELISA Kit, Abbexa, abx395169
Avelumab ELISA Kit is a quantitative ELISA kit for detection of Avelumab.Avelumab (Bavencio®) is a fully human anti-PD-L1 IgG1 lambda monoclonal antibody that has a molecular weight of approximately 147 kDa. Avelumab binds PD-L1 and blocks the interaction between PD-L1 and its receptors PD-1 and B7-1. By inhibiting PD-L1 interactions, avelumab is thought to enable the activation of T-cells and the adaptive immune system. By retaining anative Fc-region, avelumab is thought to engage the innate immune system and may induce antibody-dependent cell-mediated cytotoxicity. Importantly, avelumab has not shown antibody-dependent cell mediated cytotoxicity against immune cell subsets in humans.
Host
Reactivity
Human
Applications
ELISA
Conjugation
Please provide the required information below so that we can quickly source your products.